Medical technology leader Boston Scientific Corporation is set to make significant appearances at two major events in early 2025. The company will participate in the prestigious J.P. Morgan Healthcare Conference, followed by a webcast discussing its fourth-quarter financial results. These engagements highlight Boston Scientific's commitment to advancing healthcare solutions and maintaining transparency with investors.

Leadership Presentation at J.P. Morgan Healthcare Conference

Boston Scientific's top executives will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on January 13, 2025. This event offers an opportunity for the company to showcase its innovative medical technologies and strategic initiatives. Chairman and CEO Mike Mahoney will lead the presentation, accompanied by key members of the executive team.

The conference will feature a comprehensive overview of Boston Scientific's latest advancements in medical devices and therapies. During the session, Mahoney will be joined by Dan Brennan, Executive Vice President and Chief Financial Officer, and Kenneth Stein, M.D., Senior Vice President and Chief Medical Officer, for an interactive Q&A with analysts. This dialogue aims to provide insights into the company's vision for improving global healthcare outcomes through cutting-edge technology. Attendees can expect discussions on how Boston Scientific continues to address unmet patient needs while reducing healthcare costs.

Fourth-Quarter Financial Results Webcast

On February 5, 2025, Boston Scientific will host a webcast to discuss its financial performance for the fourth quarter of 2024. This event underscores the company's dedication to keeping stakeholders informed about its business activities and achievements. The webcast will be led by Mike Mahoney and Dan Brennan, providing detailed analysis and updates on the company's financial health.

Prior to the webcast, Boston Scientific will release a news statement summarizing its fourth-quarter financial results. The webcast will delve deeper into these figures, offering context and explanations for any notable trends or changes. Investors and analysts will have the chance to ask questions and gain a clearer understanding of the company's financial trajectory. Both the live webcast and replay will be available online, ensuring accessibility for all interested parties. Through these efforts, Boston Scientific demonstrates its commitment to transparency and accountability in its operations.